<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1269">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05144633</url>
  </required_header>
  <id_info>
    <org_study_id>21.0389</org_study_id>
    <nct_id>NCT05144633</nct_id>
  </id_info>
  <brief_title>Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)</brief_title>
  <acronym>BEA-BEST</acronym>
  <official_title>Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eko Devices, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study that will be enrolling University of Louisville patients who&#xD;
      present to the Emergency Department in Acute Respiratory Failure. This study will be to&#xD;
      determine if the addition of Eko AI-assisted lung auscultation examination to a standard of&#xD;
      care Pulmonary POCUS + assists with acute respiratory failure diagnosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Once identified and consented, the subject will undergo both POCUS and AI-assisted lung&#xD;
      auscultation using an Eko CORE stethoscope. The POCUS protocol described here is the standard&#xD;
      of care for patients who present in acute respiratory failure to the Emergency Room and both&#xD;
      groups will receive this standardized care during the study.&#xD;
&#xD;
      Upon hospital discharge, the final discharge diagnosis will be used as the ground truth for&#xD;
      assessing the accuracy of the POCUS protocol. The POCUS exam and the EkoAI exam may be&#xD;
      performed wherever the subject is located in the hospital when first enrolled in the study.&#xD;
      If possible, both exams should be performed immediately, in either order. They will be&#xD;
      performed by the same examiner.&#xD;
&#xD;
      Both the POCUS and the EkoAI exam will be analysed by an investigator blinded to the final&#xD;
      diagnosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 9, 2021</start_date>
  <completion_date type="Anticipated">August 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Measure the accuracy of POCUS for the diagnosis of acute respiratory failure</measure>
    <time_frame>1 year</time_frame>
    <description>POCUS consists of an ultrasound examination at bedside. We will perform lung ultrasound and the pattern of lung ultrasound will be used to diagnose the cause of acute respiratory failure. The reference standard will be the the final diagnosis by the clinician. The accuracy measures will include sensitivity, specificity, positive predictive value, and negative predictive value.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measure the accuracy of POCUS plus Eko for the diagnosis of acute respiratory failure. AI-assisted lung auscultation for the diagnosis of the case of acute respiratory failure.</measure>
    <time_frame>1 year</time_frame>
    <description>POCUS was described above. Ekos consists of a digital stethoscope. The lung auscultation pattern will be used to determine the cause of acute respiratory failure. POCUS and Eko will be integrated to establish the cause of acute respiratory failure. The reference standard will be the final diagnosis by the clinician.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Agreement between POCUS and Eko CORE</measure>
    <time_frame>1 year</time_frame>
    <description>We will measure Kappa statistic.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Acute Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Acute Respiratory failure</arm_group_label>
    <description>Patients presenting to the Emergency Department in acute respiratory failure. These patients may or may not have a diagnosis of chronic lung disease.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Auscultation</intervention_name>
    <description>This study will be to determine if the addition of Eko AI-assisted lung auscultation examination to a standard of care Pulmonary POCUS + assists with acute respiratory failure diagnosis.</description>
    <arm_group_label>Acute Respiratory failure</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients 18years and older, presenting to the Emergency Department in acute respiratory&#xD;
        failure.&#xD;
&#xD;
        These patients may or may not have a diagnosis of chronic lung disease. It may be necessary&#xD;
        to enroll more than 100 subjects in order to achieve 100 completed datasets.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults aged 18 years or older presenting to the ED or admitted to the hospital within&#xD;
             12 hours of enrollment&#xD;
&#xD;
          -  Acute respiratory failure defined as new onset shortness of breath initiated within&#xD;
             the last 7 days, and new or increasing need for oxygen therapy&#xD;
&#xD;
          -  The patient or patient's legal health care proxy consents to participation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Unwillingness to consent&#xD;
&#xD;
          -  Patients with trauma as the cause of ARF&#xD;
&#xD;
          -  Patients with pneumothorax as the cause of ARF&#xD;
&#xD;
          -  Inability to perform pulmonary POCUS or lung auscultation (e.g. dressing on the chest)&#xD;
&#xD;
          -  Unwilling or unable to complete the minimum of 12 lung sound stethoscope recordings.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rodrigo Cavallazzi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrea M Reyes Vega, M.D.</last_name>
    <phone>5028528884</phone>
    <email>a0reye02@louisville.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rodrigo Cavallazzi, M.D.</last_name>
    <email>rodrigo.cavallazzi@louisville.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodrigo Cavallazzi, MD</last_name>
      <phone>502-852-5841</phone>
      <email>r0cava01@louisville.edu</email>
    </contact>
    <contact_backup>
      <last_name>Andrea Reyes, MD</last_name>
      <phone>5028528884</phone>
      <email>andrea.reyesvega@louisville.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 1, 2021</study_first_submitted>
  <study_first_submitted_qc>November 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2021</study_first_posted>
  <last_update_submitted>November 19, 2021</last_update_submitted>
  <last_update_submitted_qc>November 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Louisville</investigator_affiliation>
    <investigator_full_name>Rodrigo Cavallazzi</investigator_full_name>
    <investigator_title>MD, Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

